1.
Bioorg Med Chem Lett
; 17(5): 1250-3, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17189692
RESUMEN
A new class of bicyclic pyrrolopyrimidine-based Janus kinase 3 (JAK-3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK-3.